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ABSTRACT 
Cultures  of  dissociated  rat  superior  cervical  ganglion  neurons  (SCGN)  were 
treated with the sympatholytic agent, guanethidine.  When treated within the first 
couple of weeks in vitro, the neurons were rapidly destroyed. The cells grew less 
susceptible  to the  toxic effects of guanethidine  with age in vitro.  Moreover, the 
apparent  affinity,  Kin,  of the  transport  molecule  for  norepinephrine  (NE)  and 
guanethidine  remained  essentially  unchanged between  2  and 7  wk in culture,  as 
did  the  maximum  velocity of transport  (Vma~).  This  is  at  a  time  when  previous 
studies  have  shown  these  neurons  to  be  using  acetylcholine  (ACh)  as  their 
neurotransmitter.  Cultures which were  grown without supporting cells and from 
which cholinergic  synaptic interactions  were  recorded physiologically were  proc- 
essed  for  autoradiography  after  incubation  with  [3H]NE.  All  cell  bodies  and 
processes seen had silver grains accumulated over them. 
These experiments show that sympathetic neurons in vitro maintain their amine 
uptake system relatively unchanged, even though they use ACh as their transmit- 
ter. The implications of these findings are discussed. 
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It  has  been  known  for  many  years  that  target 
tissues perform a maintenance function necessary 
for  the  survival  of  innervating  neurons.  Until 
recently, little  was known about how much envi- 
ronmental  (cellular  and  humoral)  interactions 
could influence the specific differentiated proper- 
ties of a neuron. Over the last few years, however, 
it has become clear that  at least  the  neurotrans- 
mitter that  a  neuron releases  can be  effected by 
external factors (41, 43, 51). We were interested 
in whether other neuronal properties were altered 
under  conditions  which  induced  a  neuron  to 
change its neurotransmitter. 
Evidence  for  neurotransmitter  plasticity  has 
come  from  work  on  rat  sympathetic  neurons 
grown in vitro. Cultures of dissociated rat superior 
cervical  ganglion  neurons  (SCGN)  have  been 
shown to form synapses with each other (6,  51, 
56)  and  with  co-cultured  skeletal  muscle  cells 
(reference 48 and E. Wakshull,  unpublished ob- 
servations). These synaptic connections have been 
shown by pharmacological criteria to be choliner- 
gic  (13,  41,  51).  These  findings  cannot  be  ex- 
plained by a selective survival of those cholinergic 
sympathetic  neurons  reported  to  exist  in  some 
sympathetic  ganglia  (1,  5,  61,  68)  because  the 
neurons are essentially postmitotic in culture and 
their  numbers  are  stable  from the  first  week  in 
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121 vitro.  There  is  also  a  gradual  shift  in  synaptic 
vesicle cytochemistry in virtually all the  cells ex- 
amined (reference  40; see  also  discussion in ref- 
erence 54).  After  1 wk in vitro, synaptic vesicles 
are  of  the  dense-core  type,  which  is  typical for 
adrenergic sympathetic neurons in vivo (59). Dur- 
ing  the  ensuing  weeks  in  culture,  the  vesicle 
population  becomes  increasingly  agranular  or 
clear,  and  after  8  wk  in  vitro  synaptic  profiles 
contain predominantly clear  vesicles  (40).  Con- 
comitant with these changes, and beginning at 2- 
3 wk in vitro, a dramatic increase is seen in choline 
acetyltransferase  (CAT)  activity  and  in  the  fre- 
quency and efficacy of cholinergic synaptic trans- 
mission between these sympathetic neurons. 
Despite  this  shift  to  cholinergic  mechanisms, 
these dissociated sympathetic neurons retain some 
properties  characteristic  of  adrenergic  neurons. 
There is a  50-fold increase in the ability of these 
cells to synthesize catecholamines (dopamine and 
norepinephrine) from L-tyrosine during their first 
3 wk in vitro (44). When these neurons are grown 
in the  presence  of supporting cells under condi- 
tions  known  to  allow  expression  of  cholinergic 
transmission (38,  39),  they  are  still able to  take 
up  exogenous  norepinephrine  (NE)  with  high 
affinity (54) and to release it upon depolarization 
with high K § or veratradine in a  Ca++-dependent 
manner (12, 54). This ability persists even up to 8 
wk in culture (12). 
The  uptake  of  extracellular  NE  with  a  high- 
affinity transport  mechanism  is  characteristic  of 
adrenergic neurons both peripherally (3,  33,  34, 
36)  and  centrally  (4,  16,  29,  31,  66)  and  is 
thought to be the dominant mechanism for trans- 
mitter  inactivation  (3,  35).  The  amine  uptake 
system is also used by guanethidine, a drug which 
is used clinically in the treatment of chronic hyper- 
tension  (47,  55)  and  which  has  been  shown  to 
block the release of NE from peripheral adrener- 
gic  terminals (14,  15,  20,  21,  32,  45,  46).  Al- 
though the mechanism of this blockade has yet to 
be elucidated, it is thought that the specificity of 
this  blockade  (i.e.,  confined to  adrenergic  neu- 
rons)  is  due  to  the  use  of  the  amine  pump  by 
guanethidine to  gain entry into the  cell (15,  32, 
45,  46,  62).  It  has  also  been  shown  that,  in 
sufficiently high doses,  guanethidine will destroy 
the sympathetic nervous system in rats  (11,  38). 
However,  a  small  percentage  of  the  principal 
neurons  survive  the  drug  treatment  (2,  11).  In 
cultures of chick and rat superior cervical ganglion 
explants, guanethidine also proved to be toxic to 
virtually all the cells (37). 
The  purpose  of the  experiment reported  here 
was  to  determine  whether  any  changes  in  the 
kinetics of the amine uptake system accompanied 
the switch to cholinergic transmitter mechanism by 
these  cultures.  This study was  prompted  by the 
observation that the susceptibility of these neurons 
to  guanethidine cytotoxicity decreases  as a  func- 
tion of age in vitro (65). 
MATERIALS  AND  METHODS 
Preparation of Cultures 
Cultures of dissociated rat SCGN were established  as 
previously  described  (40),  with  some  modifications. 
Briefly, ganglia were removed from 21-day-old embryos, 
stripped mechanically of their connective tissue capsule, 
and incubated for 30-45 min in Hanks' Ca++-Mg++-free 
balanced  salt  solution  (Grand  Island  Biological  Co. 
[Gibeo],  Grand  Island,  N.  Y.)  with  0.25%  trypsin 
(Sigma  Chemical  Co.,  St.  Louis,  Mo.;  Worthington 
Biochemical  Corp.,  Freehold,  N.  J.)  at  35~  After 
extensive  rinsing in L-15  media (Gibeo), ganglia were 
triturated in standard media  (see  Table I A),  filtered 
through a Nitex filter (Tetko Inc., Elmsford, N. Y.; 15 
/.tm pore size),  and plated onto collagen-coated  Aclar 
dishes (25  mm diam) (7). Cultures were maintained at 
35~  and pH 7.3 in a COs  atmosphere. Medium was 
changed three times a week.  Most  of the experiments 
were  done on SCGN cultures free  of supporting cells 
(fibroblasts  and Schwann  cells).  This was  achieved  by 
treating the cultures from days 3-6 in vitro with media 
containing fluorodeoxyuridine (Table  I B).  This  brief 
treatment was usually sufficient to destroy all the sup- 
porting cells, as judged by visual inspection with phase- 
contrast microscopy. 
Cytotoxicity Experiments 
Experimental cultures were fed with standard medium 
(Table  IA)  containing 100  p.M  guanethidine sulfate 
(Ciba-Geigy Corp.,  Summit, N. J.)  and maintained at 
(approx.) pH 8.0 (35) for 48 h. Lower concentrations of 
guanethidine required a longer exposure of the cells to 
the drug. Although control cultures tolerated the alkalin- 
ity well for 48 h, some deterioration occurred if the cells 
were  maintained at the high pH for longer periods of 
time. Control cultures were similarly treated, but with- 
out the drug. At the end of the incubation period, the 
cultures were  returned to standard medium at pH 7.3. 
To assess the toxic effects of guanethidine, cell numbers 
were determined before treatment and usually 1 wk or 
more  after  cessation  of  guanethidine treatment.  The 
criteria for scoring a cell as viable  by light microscopy 
(￿  after  exposure to  the  drug were:  (a)  smooth 
plasma membrane; (b) visible  nucleus and nucleolus; 
and (c) unfragmented process  (see  Results). Although 
these  criteria  are  somewhat  subjective,  they  usually 
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Media  Solutions for transport study 
Anfimitotic 
Standard medium  medium  Prerinse  Radioactive media  Postrinse 
A  B  C  D  E 
MEM  65% (vol/vol)  78% (vol/vol)  100%  100%  100% 
Human placental serum  25% (vol/vol)  10% (vol/vol)  -  -  - 
Chick embryo extract  ..... 
Glucose  600 mg% (wt/  600 mg% (wt/  600 mg% (wt/  600 mg% (wt/  600 mg% (wt/ 
vol)  vol)  vol)  vol)  vol) 
Glutamine  1.4 mM  1.4 mM  -  - 
NGF  25-50 U/ml  25-50 U/ml  -  - 
HEPES*  -  -  25 mM  25 mM  25 mM 
EGTA~:  -  -  4 mM  4 mM  4 mM 
MgCl2  -  -  5 mM  5 mM  5 mM 
Pargylinew  -  -  10/~M  10/.tM  10/zM 
Ascorbic acid  -  -  1.2 mM  1.2 mM  1.2 mM 
Fluorodeoxyuridine  -  10/zM  -  -  - 
Uridine  -  10/xM  -  -  - 
[3H] NE  -  -  -  II  - 
[3HlGuanethidine  -  -  -  U  -- 
Cold  NEw  ....  25/.tM 
Cold guanethidine￿82  ....  200/xM 
* Sigma Chemical Co. 
:~ Ethylene  glycol-bis(/3-aminoethyl ether)  N, N'-tetra  acetic  acid  (Eastman  Organic  Chemicals  Div.,  Eastman, 
Kodak Co. (Rochester, N. Y.). 
w Not used for [3H]guanethidine uptake. 
II See figure legends for concentrations. 
￿82  Not used for [3H]NE uptake. 
proved adequate  for our purposes, due  to the  striking 
difference in appearance between the effected cells and 
either  those  that  remained  viable  or  the  control  cells 
(Fig. 2). 
Transport Experiments 
The uptake and accumulation of [aH]NE (3.8-5.9 Ci/ 
mmol;  New  England  Nuclear,  Boston,  Mass.)  and 
[3H]guanethidine  (0.12  Ci/mmol;  kindly  provided  by 
Dr. A. M. White, Ciba, Horsham, England) was studied 
as a function of age in vitro and drug concentration. The 
purity of the  [SH]guanethidine was confirmed by paper 
chromatography. Cultures were  preincubated with sev- 
eral changes of prerinse solution (see Table I C) for 20- 
30  minutes at  30~176  Preliminary  studies had indi- 
cated  that  [aH]guanethidine  uptake  was  linear  for  45 
min. Therefore, the radioactive incubation solution (Ta- 
ble  ID)  was left on the cultures for  15  min, to insure 
constant rates of uptake, after which they were removed 
into a 5~  cold room and rinsed repeatedly with ice-coLd 
postrinse (Table  I E) contianing an excess of nonradio- 
active  carrier.  This  was  done  to  remove  nonspecific 
extracellular  binding  of label.  Control  studies showed 
that  uptake  of  [aH]NE  and  [aH]guanethidine  was  in- 
hibited 99  and 97%,  respectively, by incubation in the 
cold (5~  The pH of the solutions was 7.2 for [aH]NE 
and  8.0  for  [SH]guanethidine  uptake.  Initial  studies 
indicated no difference in the uptake of [3H]guanethidine 
between pH  7.2  and 8.0;  therefore,  the latter pH was 
used  to  parallel  the  cytological  experiment.  Cultures 
were  subsequently dried,  solubilized,  and counted in a 
Beckman LS-235  liquid scintillation counter (Beckman 
Instruments, Inc., Fullerton,  Calif.).  Counting efficien- 
cies (25-35 %) were determined by the external standard 
ratios  method,  and  all  counts were  corrected  accord- 
ingly.  Samples  were  run  in  triplicate  (except  where 
noted), and uptake values are given as mean -  SE on a 
per neuron basis. For the kinetic data, the uptake of the 
two  compounds was determined  as a  function of drug 
concentration.  Double-reciprocal  plots  of  uptake  vs. 
substrate concentration were drawn and a linear regres- 
sion analysis of the points gave the values for Km and 
Wmax. 
Electrophysiological Experiments 
The development of synaptic interactions between the 
SCGN was assayed in these cultures with physiological 
techniques,  as  previously  described  (41).  Recordings 
were obtained simultaneously from two neurons with a 
pair  of intracellular  electrodes.  These  ceils  were  then 
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to determine whether synaptic connections existed be- 
tween the pair of cells. When synaptic potentials were 
seen, the culture was usually perfused with hexametho- 
nium (bromide salt; Sigma Chemical Co.),  a nicotinic 
receptor  antagonist,  to  establish whether  cholinergic 
transmission was present. A blocked synaptic potential 
had to recover upon return to control medium before it 
was considered a positive pharmacological  observation. 
Autoradiography 
A combined physiology and autoradiography experi- 
ment was used as an additional test of whether a neuron 
could express cholinergic transmission together with a 
persistent amine uptake system. Cholinergic driver cells 
were identified as described above, and their positions 
were noted on a scored culture dish. The culture was 
then incubated for 30 min at room temperature with 11 
/xCi  [3H]NE  in N-2-hydroxyethylpiperazine-N'-2-eth- 
anesulfonic acid (HEPES)-buffered minimum essential 
medium (MEM; pH 7.4) at a concentration of 0.78 tzM 
and  diluted  with 1.56 /~M  cold NE.  After  loading, 
cultures were rinsed repeatedly with HEPES-buffered 
MEM  for  a  further  90  min  and  fixed overnight in 
Karnovsky's two-step aldehyde procedure (57) at 4~ 
The culture was then washed with 0.1  M cacodylate, 
dried, and coated with Kodak NTB2 emulsion. After 
exposure for  1 wk  at  0~  the  autoradiographs were 
developed with Kodak D-19,  and counterstained with 
thionin. 
RESULTS 
Transport Experiment 
The  accumulation  of  [3H]NE  and  [3H]- 
guanethidine by  supporting cell-free  cultures of 
SCGN increased by three- and eight-fold, respec- 
tively, between 11/2 and 71/2 wk in vitro (Fig. 1). 
The 40-fold greater uptake of guanethidine com- 
pared to NE (cf.  ordinate scales in Fig. 1) is due 
in large  part  to  the  difference  in concentration 
between the two drugs during incubation (100 and 
0.2  p.M,  respectively), although  this  is  not  the 
only explanation (see kinetics, below). Incubation 
in the cold inhibited the uptake of both drugs by 
>95%,  indicating that the  transport is probably 
not a simple diffusion process. Transport was also 
decreased by desmethylimipramine (5 /~M; Geigy 
Pharmaceuticals, Ardsley, N. Y.), a potent antag- 
onist of the  amine uptake  system  (3,  33);  NE 
uptake  was  0.34%  of control and guanethidine 
uptake was 35% of control. The difference in the 
degree  of  inhibition for  the  uptake  of  the  two 
drugs again probably results from  concentration 
differences in the  incubation solutions (0.2  /zM 
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FIGURE 1  Uptake of [aH]NE and [aH]guanethidine as 
a  function of  age  in  vitro.  Cultures were treated  as 
described in Materials and Methods, In all cases, the 
drug concentrations were 0.2 and 100 v.M for [aH]NE 
and  [3H]guanethidine, respectively. Each  point repre- 
sents the mean +- SE of three cultures. The point without 
error bars represents the average of two cultures. 
for NE,  100  tzM for guanethidine). These data, 
taken together, further indicate (see Introduction) 
that guanethidine uses the amine uptake pump to 
get into these cells. 
These findings also demonstrated that the  up- 
take  of  both  NE  and  guanethidine into  SCGN 
increased as a function of age in vitro, up to 7 wk. 
At this age in vitro, several studies have demon- 
strated that from 5 to 70% of the neurons inter- 
connect  with  cholinergically mediated  synapses 
(40, 41, 51). As will be shown in the Physiology 
and Autoradiography section, SCGN grown with- 
out  supporting cells  also  display  a  considerable 
degree of cholinergic interaction. Thus, although 
it appeared  that these  cells were  switching from 
adrenergic  to  cholinergic  neurotransmission, at 
least one feature characteristic of adrenergic neu- 
rons, the amine pump, was retained by the neu- 
rons for at least 2 mo in vitro. 
It  seemed  important,  therefore,  to  ascertain 
quantitatively whether the  properties  of the  up- 
take  pump changed with  age  in culture. Conse- 
quently, the  kinetic  parameters,  Km  and  Vm~, 
were determined for NE and guanethidine trans- 
port at various times in vitro. Table II shows the 
result  of  a  linear regression  analysis of  double 
reciprocal plots  obtained from the  uptake  data. 
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Kinetics of  [aH]NE and [SHlGuanethidine Uptake as a Function of  Age in Culture* 
NE  Guanethidine 
Days in vitro  K=  V~  R:~  P  KM  V=~  R:~  P 
taM  fmollcell/15'  ~  fmol/cell/ l 5' 
14  0.91  38.1  0.995  0.005  0.43  61.6  0.990  0.005 
47  1.5  150  0.998  0.05  1.03  222  0.920  0.12 
* Cultures were treated as described in Materials and Methods. Various concentrations of [aH]NE (0.1, 0.2, 0.5, 2.0 
/xM at 13 days in vitro; 0.2, 0.5, 2.0/~M at 46 div) and [SH]guanethidine  (0.5, 0.67, 1.0, 5.0/,~M at 14 div; 0.5, 1.0, 
5.0/~M at 48 div) were used in the incubation medium. Data were graphed in double reciprocal form (one/uptake 
vs. one/substrate concentration) and analyzed for Km and V~ with a linear regression program on a desk calculator. 
:~ Correlation coefficient of linear regression. 
The  values for  Kin,  which  is  a  measure  of the 
apparent affinity of the substrate for the transport 
molecule (strictly speaking, it cannot be consid- 
ered an affinity constant since equilibrium condi- 
tions cannot be  assumed),  are  similar for  both 
drugs: 0.9/zM for NE and 0.43 gM for guanethi- 
dine at 2 wk in vitro. Considering the variability 
inherent in the tissue culture system and because 
the  low  specific  activity of the  [aH]guanethidine 
makes measurements at low concentrations inac- 
curate, the Km's are essentially the same. More- 
over, these values change very little over the 5-wk 
interval between data points. Although the  Vmax 
for guanethidine is almost twice that of NE, both 
values increase  approx,  fourfold  over  the  time- 
course studied. Similar values for Km and Vm~x for 
NE uptake have been reported for cultures of rat 
SCGN by Patterson et al. (54). 
Cytotoxicity Experiments 
Previous  studies  of  guanethidine  toxicity  on 
cultured explants of chick and rat  SCG demon- 
strated a requirement for alkaline conditions (pH 
7.8-8.0) in order for toxic effects to be observed 
(37). Preliminary work on dissociated rat SCGN 
replicated this finding, but transport experiments 
at pH 7.2 and 8.0 showed no difference in the net 
uptake  of [aH]guanethidine. Although no expla- 
nation  for  this  high  pH  condition  is  currently 
available, all  subsequent incubations with guan- 
ethidine  (or  control) were  done  at  the  elevated 
pH. 
Neurons  treated  at  1-2  wk  in  vitro  showed 
changes in their light microscope  appearance in 
<2  days. Processes took on a  beaded discontin- 
uous  appearance  (or  "blebbed";  see  reference 
23),  the  somal cytoplasm became  granular and 
vacuolated,  and  the  plasma  membrane became 
irregular in its contours. These changes continued 
after guanethidine removal until fragmentation of 
the processes and disintegration of the cell body 
signaled neuronal demise (Fig. 2b). Control cul- 
tures  displayed  normal  neuronal  morphology, 
demonstrating that the 48 h  at pH  8.0 or above 
was not deleterious to the appearance of the cells 
(Fig. 2a). Cultures treated at later in vitro stages 
manifested similar cytologic  changes,  but  these 
were delayed in onset. 
Cell  counts  of  the  young cultures  at  various 
times after cessation of drug treatment showed a 
rapid  decline  in  the  number of  viable  neurons 
until <10%  of the cells remained, while control 
cultures  showed  no  change  in  cell  number.  In 
older cultures, fewer cells were destroyed (Table 
III) by the treatment regimen, although most of 
the cells were affected to some degree. This result 
indicated that the older neurons were more resist- 
ant to  the  effects  of guanethidine. It  should be 
noted, however, that the percentage of cells sur- 
viving the treatment was subject to wide variation 
(Table III). Part of this variability may be due to 
the need for alkaline pH in order for guanethidine 
to  be toxic (see  above); cultures incubated with 
guanethidine had  a  tendency to  become  acidic, 
whether the medium had a bicarbonate or HEPES 
buffer  system.  Those  cultures  in  which  acidity 
became  a  problem  suffered  less  severe  cell  de- 
struction than those which remained at the alka- 
line pH for the duration fo the incubation period. 
This problem was most evident in cultures of high 
cell density (>3,500).  This does not completely 
rule out the  possibility that the variability in cell 
survival is a real phenomenon. Partly because of 
this variability, no consistent sparing of a subpop- 
ulation of cholinergic sympathetic neurons could 
be detected. 
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guanethidine treatment of 1-wk-old cultures. (a) Control culture, incubated at pH 8.0 without guanethi- 
dine. Processes remain intact and the neuronal somas round, with a few nuclei and nucleoli visible. Most 
of the neurons in clusters are out of the plane of focus. Supporting cells, which are more sensitive to the 
high pH than the neurons (E. Wakshull, unpublished observations), account for the debris in this field. 
(b) This culture was treated with 100/~m guanethidine at pH 8.0, as described in Materials and Methods. 
Destruction of the neurons is complete at this stage, with only fragmented debris left to identify where cell 
bodies (arrows) and processes had been. Bar (for a  and b) 30/zm.  ￿  350. 
TABLE III 
Effect of In Vitro Age on Guanethidine Toxicity 
Days 
Culture  Treatment*  in vitro~  Survivalw 
% 
1  Control  12  104w 
2  100 ~M guanethidine  12  0 
3  100/.tM guanethidine  12  0 
4  100 ~M guanethidine  26  46 
5  100/.~M guanethidine  26  16 
6  100/xM guanethidine  41  59 
7  100 #M guanethidine  41  37 
* Incubation at approx, pH 8.0. 
:~ Age at the time of treatment. 
w The  fact  that this number is  not  100%  reflects  the 
counting variability, which  was  never  >10%  between 
two observers counting the same culture, or one observer 
counting the same culture twice. 
Physiology and Autoradiography 
From  their  observations  in  the  physiology  of 
SCGN  cultures,  O'Lague,  et  al.  (51)  concluded 
that  few,  if  any,  synaptic  interactions  could  be 
found in cultures free of supporting cells. Because 
the  uptake  experiments  were  done  on  such  cul- 
tures  (to  eliminate  complications  introduced  by 
the  presence  of  non-neuronal cells),  several  cul- 
tures  sisters  to  those  used  for  uptake  and  other 
cultures taken randomly from various culture  se- 
ries grown without supporting cells were examined 
physiologically for the presence  of synaptic inter- 
actions. The findings are summarized in Table IV. 
As can be seen,  a  substantial number of "driver" 
neurons could be found, although in some cultures 
no synapses were found even at long in vitro times. 
The time-course of development of synaptic inter- 
actions  in  these  "pure"  neuronal  cultures  was 
similar to that found in cultures grown with non- 
neuronal cells (cf. series 533 with data in reference 
40). Thus, the presence of non-neuronal cells per 
se is not necessary for the expression of cholinergic 
synaptic transmission. 
From  the  two  cultures  which  were  examined 
physiologically  (Table  IV,  culture  nos.  442-20, 
21) and processed for autoradiography,  a  total of 
55  cells  were  penetrated,  and  nine  driver  cells 
were  found.  Although  not  all  of  these  synaptic 
potentials  were  investigated  pharmacologically, 
we  believe  it  probable  that  all  are  cholinergic 
126  THE  JOURNAL OF  CELL  BIOLOGY. VOLUME  79,  1978 TABLE IV 
Synaptic  Transmission  in SCG Cultures Free of 
Supporting  Cells 
A 
Neurons  B  B/A ￿ 
Culture*  recorded  Synapses  100  Age 
%  m~r~n  days  m vitro 
350-16  9  0  0  69 
36625  3  0  0  47 
38&16  25  0  0  51 
410E-3  8  2  25  43 
442-20~  18  4  22  24 
442-21~  37  5  14  28 
533-20  12  0  0  11 
533-6  24  0  0  13 
533-4  27  0  0  15 
533-5  30  0  0  20 
533-9  26  1  4  22 
533-11  38  8  21  28 
563-26c  13  0  0  49 
677  22  10  45  34 
722  20  1  5  38 
* The  first number indicates  the  culture  series; the 
second number indicates a particular culture within the 
series; thus, all the 533 cultures were "sister" cultures. 
Note appearance of synapses vs. age in this series (cf. 
reference 42). 
~t Also processed for autoradiography. 
because no other type of synaptic interactions has 
been desribed in an SCGN culture. Fig. 3 a and b 
shows an autoradiograph of a  culture previously 
used for physiology and prepared as described in 
Materials and Methods. Silver grains appear over 
every cell, indicating that all of the neurons were 
capable of taking up exogenous NE. Figure 3c-f 
shows recordings made from two cells in a culture 
sister  to  the  one  shown  in  Fig.  3a,  and  also 
processed for autoradiography. As shown in Fig. 
3d,  these  neurons  were  synaptically  intercon- 
nected. The  synaptic potential was  shown to  be 
sensitive  to  hexamethionium  (Fig.  3e).  These 
cells,  which  had  silver grains concentrated over 
them (but not so striking as in Fig. 3a and b), are 
therefore  capable  of  taking  up  exogenous  NE 
while  using acetylcholine (ACh)  as  their neuro- 
transmitter. 
DISCUSSION 
Two basic conclusions can be drawn from these 
results: First, the  amine uptake system does not 
significantly change either in its affinity for sub- 
strate or in the density of the transport molecules 
in the surface membrane (see below), even though 
these  neurons  make  cholinergic  synapses  with 
each other (40, 41, 50, 51). Second, dissociated 
sympathetic neurons in culture are destroyed by 
guanethidine  treatment;  this  is  consistent  with 
both in vivo (2,  11,  17,  26,  27,  37-39)  and in 
vitro (25, 28, 37) observations on rat sympathetic 
neurons. Despite some variability, as the neurons 
mature  in  culture  they  tend  to  become  more 
resistant to  the  toxic effect of guanethidine (see 
Table III). 
Destruction of the cells upon exposure to guan- 
ethidine  involved  progressive  chromatolytic 
changes in the cytoplasm, nucleus, and cell mem- 
brane. No evidence of axon retraction was seen 
(cf. references 25 and 28), although in established 
dissociated cultures this would be difficult to de- 
tect.  The  variability  in  the  percentage  of  cell 
survival after guanethidine treatment within and 
between  different  culture  series  precluded  our 
attempts to show a subpopulation  of (presumably) 
cholinergic neurons which  might be  resistant to 
the  drug  because  of  their  cholinergicity. There 
was,  however, a  definite trend toward increased 
resistance  to  drug  treatment  with  age  in  vitro 
(Table III), even though guanethidine uptake in- 
creased with age in culture (Fig. 1). This suggests 
that some (as yet unknown) metabolic change(s) 
within the neurons accounts for their resistance, 
rather than a  lowering of intracellular guanethi- 
dine concentration. Since this decreased suscepti- 
bility has been described in vivo (39), where 90- 
95%  of sympathetic cells are  clearly adrenergic 
(68), it is unclear whether the switch to choliner- 
gicity by the  SCGN in vitro contributed to their 
altered sensitivity to  guanethidine. One implica- 
tion that comes out of these observations is that 
the  neurons that  survive guanethidine treatment 
in the animal (2,  11) may not be just the cholin- 
ergic  principal  sympathetic  cells  (see  reference 
25). 
The finding that cholinergic synapses could be 
found without undue difficulty in SCGN cultures 
free of non-neuronal  cells requires comment, since 
this observation contradicts previously published 
results (50, 51).  Because both groups of investi- 
gators  use  the  same  starting  material  for  the 
culture  tissue  (embryonic  rat  superior  cervical 
ganglia),  the  cause  of  the  discrepancy  is  most 
likely the  culture  conditions and,  more  specifi- 
cally, the  culture medium. Table I A  shows  the 
standard  maintenance feed  used  in  the  present 
study; high levels of human placental serum and 
WAKSHULL, JOHNSON, AND  B~TON Amine Uptake System in Cultured Neurons  127 FIGURE  3  Autoradiographs  of  cultures  incubated  with  [aH]NE  after  physiological  identification  of 
cholinergic driver neurons. Cultures were incubated with [aH]NE and processed for autoradiography as 
described in Materials and Methods. Intracellular recordings (c-f) were obtained as described in Materials 
and Methods.  (a) Low-power autoradiograph of supporting cell-free SCGN culture.  Every neuron, as 
well as all the processes visible in the culture, were virtually opaque with silver grains, as shown in this 
field.  (b) A  higher-power view of a  single neuron is this same culture shows the grains more clearly, 
particularly over the finer neurites.  (c) Action potential, elicited by anode  break excitation, in driver 
neuron. Break in baseline indicates initiation of current injection. (d-f) "Receiver" neuron. Initial small 
downward and upward deflection on the extreme left of each recording trace indicates stimulus artifact. 
Stimulation of neuron in Fig. 3c produced a synaptic potential in the receiver cell, which was blocked by 
perfusion with 10  -4 M hexamethonium (C-6) (e). (f) Return to control solutions allows the recovery of 
the synaptic potential. The neurons in Fig. 3 c-f taken from a culture sister to that shown in Fig. 3 a and 
b also had silver grains accumulated over them, but had too high a background for photographic purposes. 
Bar (for a) 100 p.m; (for b) 25  /~m. (c) 25 mY, 10 ms. (d-f) 2,5 mV, 10 ms. (a)  ￿  105; (b) x  420. 
9-day  old chick embryo extract (25  and  10%  by 
volume, respectively), are present. These ingredi- 
ents were  not  used  by  O'Lague  et  al.  (50,  51). 
Recent  evidence  from  our  laboratory  (reference 
60  and D.  Ross,  unpublished observations) indi- 
cates that these two components of the media act 
to increase CAT levels in cultured SCGN in much 
the  same  way  as  media  from  non-neuronal  cell 
cultures (conditioned media;  53).  Thus,  it seems 
probable that the same factor or factor(s) similar 
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substantial  variety  of  cellular  sources  (53),  is 
present in our media and acts to increase the ACh 
through increaseed CAT activity. 
In each of the cultures studied with the autora- 
diographic method, extensive labeling was found 
over all of the neurons and their processes. It is 
possible  that  the  labeling is  due  to  nonspecific 
binding  of  [aH]NE  to  the  culture.  Two  points 
render this objection untenable.  First, one  must 
propose a differential affinity for nonspecific bind- 
ing  to  the  neuronal  membrarie  vs.  the  collagen 
substrate,  since  there  was  a  significantly higher 
density of grains over the neurons as compared to 
background (see Fig. 3a and b). Second, previous 
studies (12) on the uptake of [aH]NE into dorsal 
root ganglion cultures indicated a  virtually com- 
plete washout of radioactivity after a postincuba- 
tion rinse period comparable to that  used in the 
present study. It is, however, still conceivable that 
there  was  nonspecific  binding  to  the  neuronal 
membranes. Another possibility is that microelec- 
trode damage to the membrane of the driver cells 
allowed  nonspecific  leakage  of  label  into  these 
neurons.  However,  if one  assumes that the  ran- 
dom sampling of neuronal pairs accurately reflects 
the  percentage  of  cholinergic  driver  cells  in  a 
culture  (a  percentage  which,  in  fact,  probably 
underestimates  the  number  of  driver  cells;  see 
reference 41  for discussion), then other choliner- 
gic driver cells must  be present (undamaged)  in 
the culture. Given the uniformity of labeling (see 
above),  this indicates that  the  [aH]NE  was  also 
taken  up  by  undamaged  cholinergic  neurons. 
However,  the  question  of  whether  cholinergic 
sympathetic neurons in vivo have a specific amine 
uptake system remains unanswered. 
As stated above, a uniform distribution of silver 
grains was seen over the somal and neuritic mem- 
brane. Theoretically, one might have expected to 
see localization of silver grains over regions spe- 
cialized for transmitter release (i.e., synaptic ter- 
minal  and  varicosities  along  the  neuritic  proc- 
esses). It is possible that [3H]NE was taken up in 
the  terminals  and  varicosities and  subsequently 
transported throughout the cells, since iontopho- 
retic intracellular injection of horseradish peroxi- 
dase  will fill extensively the  neuronal  processes 
within 90 min (E.  Wakshull, unpublished obser- 
vations). Alternatively, evidence exists suggesting 
that NE is taken up and accumulated over most or 
all of the adrenergic neuronal surface (18, 24). A 
distinction between  these  possibilities cannot  be 
made on the basis of the data presented here. 
The  present  evidence  supports  the  idea  that 
these neurons have  a  high-affinity amine uptake 
system, and that guanethidine is transported into 
the cells via this system (Tables II and III). Both 
NE and guanethidine uptake are inhibited by cold 
temperature  and  desmethylimipramine. The  val- 
ues  for  the  kinetic  parameters,  Km  and  Vm~ 
(Table  II),  for  NE  are  comparable  to  those 
reported  in  a  similar  culture  system  by  other 
workers (53, 54), and the Km is within the range 
of values reported for peripheral adrenergic ter- 
minals in acute preparations (35,  52).  Although 
Vm~  for  both  NE  and  guanethidine  increased 
fourfold over the time period studied, the phos- 
pholipid  content  of  these  neurons,  which  is  a 
measure of total membrane  area,  also increased 
approximately  fourfold  (E.  Wakshull,  unpub- 
lished  observations).  If  one  considers  Vm~, as 
being  proportional  to  the  density  of  transport 
molecules  (64),  these  results  suggest  that  the 
neurons maintain the amine pumps at a relatively 
constant  density  on  their  surface.  This  specific 
transport  system,  therefore,  is  maintained  un- 
changed  throughout  the  in  vitro  life  of  these 
neurons.  This  finding  is  contradictory  to  that 
reported  by  Hill  and  Hendry  (30),  who  used 
catecholamine histofluorescence as a  measure of 
the uptake system and found a decrease in fluores- 
cence with age in vitro. 
What function the amine uptake pump serves in 
these neurons in culture is not known, because it 
is  clear  that  these  cells  are  using  ACh  as  a 
neurotransmitter (13, 40, 41, 51). Alternatively, 
the cells could be releasing both ACh and NE, as 
proposed by Burn and Rand (9) many years ago 
for in vivo sympathetic neurons (see also reference 
8), but because the SCGN have no demonstrable 
adrenergic receptors (reference 49  and E.  Wak- 
shull,  unpublished observations), any  release of 
NE  could  not  be  detected by  the  physiological 
methods employed. In fact, it has been shown that 
these cells not only produce NE (44, 53) but can 
also,  under  appropriate conditions, release both 
ACh  and  NE  simultaneously  onto  co-cultured 
atrial  muscle  cells  (19).  These  cases  are  rare, 
however, and may represent an immature state of 
development (58). Recent evidence indicates that 
most sympathetic neurons  in culture will choose 
one  transmitter  over  the  other  (58).  Although 
Patterson and Chun (53) have shown that cultures 
of dissociated SCGN will take up exogenous cho- 
line  to  produce  ACh,  it is not  clear from  their 
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high-affinity choline uptake system thought to be 
specific for recapturing  and recycling choline  for 
ACh synthesis (22, 23, 63, 66). Thus, while these 
normally adrenergic sympathetic neurons shift to 
"cholinergicity,"  the  high-affinity  amine  uptake 
system  (and,  by  inference,  the  protein(s)  neces- 
sary  for  its  continued  function)  is  maintained. 
Other workers have reached a similar conclusion 
(58). 
If one assumes that normally there is a regular 
turnover of membrane proteins, then the persist- 
ence  of the  amine  pump  in  cholinergic  neurons 
suggests  that  maintenance  of  the  pump,  which 
normally  is  associated  with  the  transmitter  re- 
leased by a neuron, is not regulated by the same 
factors that determine the transmitter that a neu- 
ron  will  use  (42,  43,  53;  see  also  discussion  in 
reference  58).  These findings  raise doubts  about 
the  use  of  uptake  experiments  to  identify  the 
neurotransmitter used by a neuron. 
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